Publications by authors named "Martin P Barr"

Claim this Profile
A
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLC.
Celine Mascaux, Triparna Sen, Montse Sanchez-Cespedes, Sandra Ortiz-Cuaran, Yohan Bossé, Martin P Barr

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.
David O'Reilly, Anthony O'Grady, Conor Hayes, Laura Piggott, Ruaidhri Keane, Helen Barrett, Martin P Barr

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort.
Ciara S McNevin, Anna Keogh, Mutaz Mohammed Nur, Brianán McGovern, Julie McFadden, Martin P Barr

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implication of tumor spread through air spaces in stage IA lung adenocarcinoma: prognostic impact and association with the International Association for the Study of Lung Cancer (IASLC) grade.
Jinghan Shi, Kuan Xu, Xufeng Liu, Martin P Barr, Jeffrey B Velotta

Transl Lung Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a prognostic gene signature in patients with cisplatin resistant squamous cell lung cancer.
Yi Mu, Yinan Dong, Mingyang Zheng, Martin P Barr, Giandomenico Roviello

J Thorac Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Landscape of NSCLC in the Republic of Ireland.
Rachel J Keogh, Martin P Barr, Anna Keogh, David McMahon, Cathal O'Brien

JTO Clin Res Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.
Wenping Song, Xuan Wu, Shuai Wang, Martin P Barr, María Rodríguez

Transl Lung Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Cancer in the Republic of Ireland.
Rachel J Keogh, Martin P Barr, Anna Keogh, David McMahon, Anne-Marie Baird

J Thorac Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses.
Eimear Mylod, Ellen McKenna, Maria Davern, Martin P Barr, Noel E Donlon

Clin Exp Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing an In Vitro Isogenic Model of Chemotherapy-Resistant Lung Cancer.
Martin P Barr

Methods Mol Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in -Mutated NSCLC.
Martin P Barr, Anne-Marie Baird, Sophia Halliday, Petra Martin, Emma H Allott

Diagnostics (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma.
Chun-Feng Pan, Ke Wei, Zi-Jian Ma, Yao-Zhou He, Jing-Jing Huang, Martin P Barr

Transl Lung Cancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer.
Éilis Russell, Melissa J Conroy, Martin P Barr

Cells· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol Inhibits Tumorigenesis in Cisplatin-Resistant Non-Small Cell Lung Cancer via TRPV2.
Swati Misri, Kirti Kaul, Sanjay Mishra, Manish Charan, Ajeet Kumar Verma, Martin P Barr

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DNA damage repair-related gene is a potential biomarker in various malignancies.
Changjian Shao, Yuanyong Wang, Minghong Pan, Kai Guo, Tamas F Molnar, Martin P Barr

Transl Lung Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploitation of the vitamin A/retinoic acid axis depletes ALDH1-positive cancer stem cells and re-sensitises resistant non-small cell lung cancer cells to cisplatin.
Lauren MacDonagh, Rhyla Mae Santiago, Steven G Gray, Eamon Breen, Sinead Cuffe, Martin P Barr

Transl Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer.
Lauren MacDonagh, Michael F Gallagher, Brendan Ffrench, Claudia Gasch, Steven G Gray, Martin P Barr

Transl Lung Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
Lulu Hu, Dachuan Shen, Dapeng Liang, Ji Shi, Chunyan Song, Martin P Barr

Cancer Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness.
Louise Flynn, Martin P Barr, Anne-Marie Baird, Paul Smyth, Orla M Casey

Sci Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature.
Martin P Barr, Steven G Gray, Andreas C Hoffmann, Ralf A Hilger, Juergen Thomale

PLoS One· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer.
Martin P Barr, Steven G Gray, Kathy Gately, Emily Hams, Padraic G Fallon

Mol Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
Sarah-Louise Ryan, Sam Beard, Martin P Barr, Kazou Umezawa, Susan Heavey

Lung Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?
Anne-Marie Baird, David Easty, Monika Jarzabek, Liam Shiels, Alex Soltermann, Martin P Barr

Front Endocrinol (Lausanne)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells.
Tian Ye, Ke Jiang, Liwen Wei, Martin P Barr, Qing Xu

Am J Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation.
Min Liu, Ke Jiang, Guibin Lin, Peng Liu, Yumei Yan, Martin P Barr

J Exp Clin Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis